Lv1
53 积分 2021-10-21 加入
A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells
2个月前
已完结
338 BM-1252 (APG-1252): a potent dual specific Bcl-2/Bcl-xL inhibitor that achieves complete tumor regression with minimal platelet toxicity
3个月前
已完结
Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
3个月前
已完结
Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer
3个月前
已关闭
Degrader–Antibody Conjugates: Emerging New Modality
3个月前
已完结
New insights into serum/extracellular thioredoxin in regulating hepatic insulin receptor activation
4个月前
已完结
Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors
4个月前
已完结
Current Status of Targeted Therapy for Anaplastic Lymphoma Kinase–Rearranged Non–Small Cell Lung Cancer
5个月前
已完结
Treating ALK-positive lung cancer—early successes and future challenges
5个月前
已完结
Functions of the native NPM1 protein and its leukemic mutant
5个月前
已完结
皖公网安备34019202002308
